WallStreetZenWallStreetZen

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2024)
Top healthcare stocks in 2024 ranked by overall Zen Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare
Ticker
Company
Performance Score
Market Cap
Revenue
EBITDA
Earnings
EPS
Revenue Growth Y/Y
Revenue Growth 5Y
Earnings Growth Y/Y
Earnings Growth 5Y
Earnings Date
TLSI
TRISALUS LIFE SCIENCES INC
$255.03M$21.98M-$63.18M-$63.99M-$2.6768.96%N/AN/AN/A
MMA
ALTA GLOBAL GROUP LTD
N/A$1.54M-$16.12M-$20.60M-$5.2663.35%N/AN/AN/A
SHPH
SHUTTLE PHARMACEUTICALS HOLDINGS INC
$6.92M$0.00-$4.96M-$7.35M-$0.46N/AN/AN/AN/A
CADL
CANDEL THERAPEUTICS INC
$416.43M$0.00-$33.50M-$37.37M-$1.28N/AN/AN/AN/A
MOVE
MOVANO INC
$46.07M$0.00-$28.90M-$29.28M-$0.63N/AN/AN/AN/A
AONC
AMERICAN ONCOLOGY NETWORK INC
$128.70MN/AN/AN/AN/AN/AN/AN/AN/A
YS
YS BIOPHARMA CO LTD
$95.85MN/AN/AN/AN/AN/AN/AN/AN/A
ELAN
ELANCO ANIMAL HEALTH INC
$8.42B$4.37B-$325.00M-$1.30B-$2.65-1.76%7.35%N/AN/A2024-05-30
BTSG
BRIGHTSPRING HEALTH SERVICES INC
$1.99BN/AN/AN/AN/AN/AN/AN/AN/A
RNXT
RENOVORX INC
$33.29M$0.00-$7.94M-$8.05M-$0.72N/AN/AN/AN/A2024-06-07
MTEM
MOLECULAR TEMPLATES INC
$9.55M$31.76M-$11.28M-$18.40M-$1.11-33.68%9.90%N/AN/A
ISPC
ISPECIMEN INC
$2.44M$9.27M-$9.41M-$11.57M-$1.28-14.45%N/AN/AN/A2024-05-22
MYMD
MYMD PHARMACEUTICALS INC
$4.85M$0.00-$12.29M-$17.55M-$9.57N/A-100.00%N/AN/A
EFTR
EFFECTOR THERAPEUTICS INC
$9.31M$0.00-$31.54M-$34.63M-$12.78-100.00%N/AN/AN/A
VERO
VENUS CONCEPT INC
$4.30M$73.30M-$26.52M-$37.39M-$6.68-21.70%-9.71%N/AN/A
RANI
RANI THERAPEUTICS HOLDINGS INC
$278.82M$0.00-$25.87M-$33.08M-$1.29N/AN/AN/AN/A2024-05-29
RENB
RENOVARO INC
$139.69M$0.00-$52.90M-$53.93M-$0.78N/AN/AN/AN/A
OPGN
OPGEN INC
$4.40M$3.07M-$22.42M-$26.16M-$6.51-7.28%-0.69%N/AN/A2024-06-06
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
$19.01B$16.00B$1.64B-$493.00M-$0.447.22%-1.61%N/AN/A
DRMA
DERMATA THERAPEUTICS INC
$2.20M$0.00-$8.69M-$8.69M-$1.85N/AN/AN/AN/A2024-05-16
SOLV
SOLVENTUM CORP
$10.78BN/AN/AN/AN/AN/AN/AN/AN/A
ENGN
ENGENE HOLDINGS INC
$593.58MN/AN/AN/AN/AN/AN/AN/AN/A
PMN
PROMIS NEUROSCIENCES INC
$34.13M$0.00-$11.59M-$11.89M-$0.74N/AN/AN/AN/A
ZVSA
ZYVERSA THERAPEUTICS INC
$4.12M$0.00-$105.98M-$105.53M-$1.15kN/AN/AN/AN/A
ELTX
ELICIO THERAPEUTICS INC
$106.81M$0.00-$36.83M-$38.99M-$8.63N/AN/AN/AN/A
ITRM
ITERUM THERAPEUTICS PLC
$24.67M$0.00-$32.21M-$35.58M-$2.65N/A-100.00%N/AN/A
CPHI
CHINA PHARMA HOLDINGS INC
$5.08M$6.42M-$454.86k-$3.56M-$0.68-24.11%-11.22%N/AN/A
KA
KINETA INC
$5.86M$5.16M-$16.76M-$17.89M-$1.50186.56%-5.64%N/AN/A2024-06-06
ANVS
ANNOVIS BIO INC
$97.42M$0.00-$47.53M-$47.53M-$5.13N/AN/AN/AN/A2024-06-12
APTO
APTOSE BIOSCIENCES INC
$19.25M$0.00-$46.73M-$47.17M-$6.20N/AN/AN/AN/A
GRTX
GALERA THERAPEUTICS INC
$10.33M$0.00-$38.31M-$45.75M-$0.92N/AN/AN/AN/A
NUWE
NUWELLIS INC
$4.08M$8.90M-$14.21M-$19.93M-$7.375.35%11.44%N/AN/A
BIOL
BIOLASE INC
$5.14M$48.83M-$15.50M-$38.26M-$20.340.13%1.00%N/AN/A
EHAB
ENHABIT INC
$434.35M$1.04B-$19.50M-$83.00M-$1.66-1.72%N/AN/AN/A
HCWB
HCW BIOLOGICS INC
$43.88M$1.16M-$26.12M-$27.39M-$0.7643.63%N/AN/AN/A
NRXP
NRX PHARMACEUTICALS INC
$34.56M$0.00-$25.28M-$25.65M-$3.14N/AN/AN/AN/A
CNSP
CNS PHARMACEUTICALS INC
$2.37M$0.00-$17.45M-$17.46M-$3.48N/AN/AN/AN/A
WINT
WINDTREE THERAPEUTICS INC
$2.72M$0.00-$5.32M-$5.96M-$36.34N/A-100.00%N/AN/A
LIFW
MSP RECOVERY INC
$110.80M$9.71M$274.74M-$70.31M-$6.26-49.50%N/AN/AN/A
NRSN
NEUROSENSE THERAPEUTICS LTD
$18.42M$0.00-$8.97M-$11.28M-$0.83N/AN/AN/AN/A2024-05-25
TTOO
T2 BIOSYSTEMS INC
$52.49M$7.18M-$38.59M-$45.65M-$11.51-58.15%-6.37%N/AN/A
QLGN
QUALIGEN THERAPEUTICS INC
$1.95M$0.00-$11.89M-$13.42M-$2.65N/AN/AN/AN/A2024-07-12
AMRX
AMNEAL PHARMACEUTICALS INC
$2.12B$2.50B$299.04M-$168.69M-$0.749.82%6.35%N/AN/A
CNTG
CENTOGENE NV
$11.04M$52.19M-$20.95M-$38.50M-$1.376.78%3.00%N/AN/A2024-06-28
BPTH
BIO-PATH HOLDINGS INC
$3.71M$0.00-$13.78M-$13.96M-$26.11N/AN/AN/AN/A
ATNF
180 LIFE SCIENCES CORP
$1.83M$0.00-$18.43M-$16.24M-$29.19N/AN/AN/AN/A
COCH
ENVOY MEDICAL INC
$58.60M$297.00k-$22.83M-$23.54M-$0.2138.79%N/AN/AN/A
ARMP
ARMATA PHARMACEUTICALS INC
$95.81M$4.70M-$74.07M-$79.58M-$2.20-7.28%N/AN/AN/A2024-06-12
AGEN
AGENUS INC
$226.37M$161.42M-$114.19M-$239.61M-$12.6469.94%7.01%N/AN/A
IVA
INVENTIVA SA
$194.91M$25.18M-$109.06M-$120.03M-$2.6428.59%24.86%N/AN/A2024-05-29
AMIX
AUTONOMIX MEDICAL INC
$50.56MN/AN/AN/AN/AN/AN/AN/AN/A
PACS
PACS GROUP INC
$4.19BN/AN/AN/AN/AN/AN/AN/AN/A
AKTX
AKARI THERAPEUTICS PLC
$23.14MN/AN/AN/AN/AN/AN/AN/AN/A
CDT
CONDUIT PHARMACEUTICALS INC
$219.27M$0.00-$2.01M-$2.30M-$1.25kN/AN/AN/AN/A
GALT
GALECTIN THERAPEUTICS INC
$190.17M$0.00-$41.25M-$44.78M-$0.74N/AN/AN/AN/A
MAIA
MAIA BIOTECHNOLOGY INC
$62.67M$0.00-$23.72M-$23.72M-$1.58N/AN/AN/AN/A
HCTI
HEALTHCARE TRIANGLE INC
$3.72M$33.20M-$4.10M-$12.34M-$2.92-27.64%N/AN/AN/A
ICU
SEASTAR MEDICAL HOLDING CORP
$25.79M$0.00-$32.88M-$33.67M-$1.00N/AN/AN/AN/A
ONMD
ONEMEDNET CORP
$11.93M$1.02M-$22.43M-$23.21M-$0.98-11.37%N/AN/AN/A
XFOR
X4 PHARMACEUTICALS INC
$163.91M$0.00-$120.35M-$128.91M-$0.69N/AN/AN/AN/A
SCNI
SCINAI IMMUNOTHERAPEUTICS LTD
$1.92M$0.00N/A-$10.95M-$4.94N/AN/AN/AN/A
BOLD
BOUNDLESS BIO INC
$212.09MN/AN/AN/AN/AN/AN/AN/AN/A
BCTX
BRIACELL THERAPEUTICS CORP
$26.05M$0.00-$17.21M-$12.65M-$0.80N/AN/AN/AN/A2024-06-10
BGXX
BRIGHT GREEN CORP
$40.13M$0.00-$12.49M-$13.13M-$0.07N/AN/AN/AN/A
FBLG
FIBROBIOLOGICS INC
$375.94MN/AN/AN/AN/AN/AN/AN/AN/A
OTLK
OUTLOOK THERAPEUTICS INC
$173.90M$0.00-$156.86M-$159.13M-$11.41N/A-100.00%N/AN/A2024-05-16
ONCO
ONCONETIX INC
$2.50M$58.47k-$36.71M-$37.41M-$2.19N/AN/AN/AN/A
LSDI
LUCY SCIENTIFIC DISCOVERY INC
$899.96k$16.73k-$9.75M-$11.30M-$7.00N/AN/AN/AN/A
ALLR
ALLARITY THERAPEUTICS INC
$11.97M$0.00-$11.78M-$20.94M-$410.14N/AN/AN/AN/A
MDAI
SPECTRAL AI INC
$29.20M$19.30M-$19.77M-$20.45M-$1.17-21.53%N/AN/AN/A
VINC
VINCERX PHARMA INC
$22.09M$0.00-$37.22M-$38.25M-$1.79N/AN/AN/AN/A2024-05-23
OKYO
OKYO PHARMA LTD
$38.07M$0.00-$13.18M-$13.27M-$0.61N/AN/AN/AN/A
CUTR
CUTERA INC
$51.99M$196.64M-$135.39M-$157.56M-$7.91-21.00%3.62%N/AN/A2024-07-12
BCLI
BRAINSTORM CELL THERAPEUTICS INC
$33.92M$0.00-$14.73M-$15.53M-$0.32N/AN/AN/AN/A
RVPH
REVIVA PHARMACEUTICALS HOLDINGS INC
$47.74M$0.00-$40.07M-$40.09M-$1.59N/AN/AN/AN/A
NLSP
NLS PHARMACEUTICS LTD
$5.21M$0.00-$15.36M-$15.47M-$0.50N/AN/AN/AN/A
ERNA
ETERNA THERAPEUTICS INC
$11.47M$115.00k-$19.90M-$22.92M-$4.25N/A-65.16%N/AN/A
AEON
AEON BIOPHARMA INC
$61.81M$0.00-$323.91M-$323.95M-$8.72N/AN/AN/AN/A
TVGN
TEVOGEN BIO HOLDINGS INC
$159.68M$0.00-$58.89M-$60.48M-$2.44N/AN/AN/AN/A
OCEA
OCEAN BIOMEDICAL INC
$59.42M$0.00-$97.33M-$98.59M-$3.91N/AN/AN/AN/A
ALUR
ALLURION TECHNOLOGIES INC
$92.06M$48.78M-$44.97M-$58.20M-$3.69-25.60%N/AN/AN/A
DHAI
DIH HOLDING US INC
$64.47M$0.00$640.20k$640.20k$0.05N/AN/A-82.14%N/A
PBM
PSYENCE BIOMEDICAL LTD
$11.41M$0.00$1.52M$1.52M-$0.01N/AN/AN/AN/A
INKT
MINK THERAPEUTICS INC
$36.12M$0.00-$20.37M-$20.59M-$0.59N/AN/AN/AN/A
NKGN
NKGEN BIOTECH INC
$26.00M$0.00-$80.64M-$82.95M-$5.38-100.00%N/AN/AN/A
NIVF
NEWGENIVF GROUP LTD
$10.52M$0.00-$690.85k-$690.85k-$1.23N/AN/AN/AN/A
CLDI
CALIDI BIOTHERAPEUTICS INC
$11.92M$0.00-$27.77M-$29.98M-$0.69N/AN/AN/AN/A2024-05-29

Healthcare Industries

IndustryStocks1d %1w %1m %1y %Zen ScoreP/E ratioP/B RatioROEROAROCEUpside/DownsideConsensus
679+1.36%+1.23%+2.46%-18.82%8.99x6.09x+18.75%+3.87%-27.87%+77.89%Strong Buy
64+1.59%+9.69%+11.15%+11.26%38.76x4.49x-12.99%+6.47%+11.50%+4.38%Buy
18+2.06%+2.68%+8.16%+18.10%32.52x6.45x+33.63%+8.08%+14.20%+9.62%Buy
88+0.35%+1.13%+6.63%-3.02%-1.36x2.21x+12.25%+3.32%+6.00%+33.06%Strong Buy
12+0.25%+2.09%+5.93%+3.96%25.25x3.04x+15.16%+4.73%+11.76%+13.02%Buy
59+1.55%+0.76%-0.99%-20.86%10.02x3.37x+7.22%+2.31%+5.68%+28.87%Buy
51+0.79%+2.93%+3.83%+12.22%41.77x4.66x-91.99%+6.57%+13.65%+13.52%Buy
150+1.40%+3.49%+1.94%-12.70%29.94x3.97x+7.09%+5.18%+8.05%+18.98%Buy
10+0.24%+0.94%+0.47%+26.56%26.32x105.39x-10.31%+3.43%+19.52%+10.52%Buy
56+1.69%+5.20%+6.60%-5.60%60.55x3.65x+11.24%+7.72%+10.04%+17.45%Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in May 2024?

According to Zen Score, the 3 best healthcare stocks to buy right now are:

1. Cross Country Healthcare (NASDAQ:CCRN)


Cross Country Healthcare (NASDAQ:CCRN) is the top healthcare stock with a Zen Score of 70, which is 46 points higher than the healthcare sector average of 24. It passed 22 out of 33 due diligence checks and has strong fundamentals. Cross Country Healthcare has seen its stock lose -40.55% over the past year, underperforming other healthcare stocks by -35 percentage points.

Cross Country Healthcare has an average 1 year price target of $19.50, an upside of 32.2% from Cross Country Healthcare's current stock price of $14.75.

Cross Country Healthcare stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Cross Country Healthcare, 25% have issued a Strong Buy rating, 25% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Corcept Therapeutics (NASDAQ:CORT)


Corcept Therapeutics (NASDAQ:CORT) is the second best healthcare stock with a Zen Score of 67, which is 43 points higher than the healthcare sector average of 24. It passed 22 out of 33 due diligence checks and has strong fundamentals. Corcept Therapeutics has seen its stock return 15.67% over the past year, overperforming other healthcare stocks by 21 percentage points.

Corcept Therapeutics has an average 1 year price target of $40.67, an upside of 46.13% from Corcept Therapeutics's current stock price of $27.83.

Corcept Therapeutics stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Corcept Therapeutics, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Incyte (NASDAQ:INCY)


Incyte (NASDAQ:INCY) is the third best healthcare stock with a Zen Score of 64, which is 40 points higher than the healthcare sector average of 24. It passed 20 out of 33 due diligence checks and has strong fundamentals. Incyte has seen its stock lose -13.82% over the past year, underperforming other healthcare stocks by -8 percentage points.

Incyte has an average 1 year price target of $74.92, an upside of 31.33% from Incyte's current stock price of $57.05.

Incyte stock has a consensus Buy recommendation according to Wall Street analysts. Of the 13 analysts covering Incyte, 30.77% have issued a Strong Buy rating, 23.08% have issued a Buy, 46.15% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 72 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Mei Pharma (NASDAQ:MEIP)


Mei Pharma (NASDAQ:MEIP) has an annual dividend yield of 56.36%, which is 54 percentage points higher than the healthcare sector average of 2.77%.

Mei Pharma's dividend payout ratio of 44.6% indicates that its high dividend yield is sustainable for the long-term.

2. Spok Holdings (NASDAQ:SPOK)


Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 8.16%, which is 5 percentage points higher than the healthcare sector average of 2.77%. Spok Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 148.8% indicates that its high dividend yield might not be sustainable for the long-term.

3. Sanofi (NASDAQ:SNY)


Sanofi (NASDAQ:SNY) has an annual dividend yield of 8.04%, which is 5 percentage points higher than the healthcare sector average of 2.77%. Sanofi's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Sanofi's dividend has shown consistent growth over the last 10 years.

Sanofi's dividend payout ratio of 82.1% indicates that its high dividend yield is sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 1.3% in the last day, and up 3.55% over the last week. T2 Biosystems was the among the top gainers in the healthcare sector, gaining 43.51% yesterday.

T2 Biosystems shares are trading higher after the company announced an $8 million private placement.

What are the most undervalued healthcare stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued healthcare stocks right now are:

1. Inmode (NASDAQ:INMD)


Inmode (NASDAQ:INMD) is the most undervalued healthcare stock based on WallStreetZen's Valuation Score. Inmode has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Inmode's stock has dropped -44.62% in the past year. It has underperformed other stocks in the healthcare sector by -39 percentage points.

2. Pacira Biosciences (NASDAQ:PCRX)


Pacira Biosciences (NASDAQ:PCRX) is the second most undervalued healthcare stock based on WallStreetZen's Valuation Score. Pacira Biosciences has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Pacira Biosciences's stock has dropped -29.17% in the past year. It has underperformed other stocks in the healthcare sector by -24 percentage points.

3. Cross Country Healthcare (NASDAQ:CCRN)


Cross Country Healthcare (NASDAQ:CCRN) is the third most undervalued healthcare stock based on WallStreetZen's Valuation Score. Cross Country Healthcare has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Cross Country Healthcare's stock has dropped -40.55% in the past year. It has underperformed other stocks in the healthcare sector by -35 percentage points.

Are healthcare stocks a good buy now?

49.71% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 32.26% over the next year.

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 27.85x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.